Status:

COMPLETED

Efficacy and Tolerability of Blephademodex Wipes

Lead Sponsor:

Laboratoires Thea

Conditions:

Demodex Blepharitis

Eligibility:

All Genders

Phase:

NA

Brief Summary

Primary Objective \- To evaluate efficacy of Blephademodex eyelid hygiene wipe treatment with a subsequent maintenance period with Blephaclean lid cleansing wipes in Demodex blepharitis, as assessed ...

Eligibility Criteria

Inclusion

  • Patient \> 18 years old, all genders
  • Able to read, to write and to fully understand German language
  • Good general health as determined by the investigator by medical history and physical appearance
  • Provision of written informed consent prior to inclusion
  • Moderate to Severe Blepharitis - grade ≥ 2 (Efron Scale)
  • Global discomfort score (GDS) ≥ 4
  • Proof of demodex infestation by at least ONE of the following:Demodex visible after lash manipulation;Cylindrical dandruff along the lash line; Lid margin itching; Madarosis

Exclusion

  • History of ocular trauma, ocular infection or intra-ocular inflammation within the 3 months before screening visit
  • History of ocular refractive surgery and any other ocular surgeries within 3 months before screening visit
  • History of ocular allergy or ocular herpes within the 3 months before screening visit
  • History of inflammatory corneal ulcer within the 6 months before screening visit
  • Sjogren syndrome or any other rheumatologic disease related dry eye
  • Concurrent treatment with other eye drops (anti-infectives, steroids, prostaglandins (but artificial tears are ok).
  • Specific Exclusion Criteria for Women:Patient who verbally confirms pregnancy or lactation; Childbearing potential woman who is not using a reliable method of contraception (oral contraceptive, intra-uterine device, subcutaneous contraceptive implant, vaginal ring, patch or condom) and is not surgically sterilised

Key Trial Info

Start Date :

September 11 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 14 2020

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04780165

Start Date

September 11 2019

End Date

May 14 2020

Last Update

March 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Consultation office

Heidelberg, Germany, 69121